A mechanistic model of pure and lipidic α-synuclein aggregation for advancing Parkinson’s therapies
Abstract Alpha-synuclein (aSyn) plays a crucial role in Parkinson’s disease, with various aggregates proposed as pathogenic triggers and therapeutic targets. However, anti-aSyn aggregation compounds often fail due to limited knowledge of the underlying molecular basis. In particular, interactions wi...
Saved in:
| Main Authors: | Elena Righetti, Luca Marchetti, Enrico Domenici, Federico Reali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Communications Chemistry |
| Online Access: | https://doi.org/10.1038/s42004-025-01558-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation
by: Chunyan Mu, et al.
Published: (2025-03-01) -
Radiological markers of CSF α-synuclein aggregation in Parkinson’s disease patients
by: Amgad Droby, et al.
Published: (2025-01-01) -
EGFR phosphorylates DNAJB1 to suppress α-synuclein aggregation in Parkinson’s disease
by: Yun-Yu Huang, et al.
Published: (2025-06-01) -
The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
by: Haoran Xiang, et al.
Published: (2025-04-01) -
Anion Binding and Aggregation of N‑Terminal α‑Synuclein Peptides
by: Ruiqing Wang, et al.
Published: (2025-05-01)